Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/30/2003US20030203425 Polyketides; glycopeptides; glycosyltransferases
10/30/2003US20030203417 Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
10/30/2003US20030203416 ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
10/30/2003US20030203411 Methods of minicell-based delivery
10/30/2003US20030203399 Proportional amplification of nucleic acids
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203395 TCF-1 nucleotide sequence variation
10/30/2003US20030203393 Using fluorescence to characterize, screen and identify mitotic cell chromosomal aberration; cancer diagnosis
10/30/2003US20030203389 Method for the 5'-cap-dependent amplification of cDNAs
10/30/2003US20030203383 Novel neurotrophic factor immunoassays
10/30/2003US20030203381 Single Nucleotide Polymorphism (SNP) testing, using two kinds of primers which are complementary to a mutant target and a wild-type target, and different in length or migration speed in electrophoresis
10/30/2003US20030203378 Based on identification of species specific 5' hinge and 3' hinge regions of U3 small nucleolar ribonucleic acid (snoRNA)
10/30/2003US20030203377 Complementary DNAs encoding proteins with signal peptides
10/30/2003US20030203376 Compositions, methods and kits for determining the presence of Mycoplasma genitalium in a test sample
10/30/2003US20030203374 Assaying cells in a biological sample to distinguish between living and dead cells
10/30/2003US20030203373 Method for identifying a pharmacologically active substance
10/30/2003US20030203369 Apparatus and method for determining a signal produced by a micro array device by comparing a signal produced by an unstructured probe to a second signal produced by a structured probe
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203360 Methods for identifying products employing gene expression
10/30/2003US20030203358 Depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined exogenous nucleic acid
10/30/2003US20030203357 Detecting and differentiating viruses or other intracellular parasites present in a specimen; compositions and methods to evaluate the susceptibility of a organisms to antimicrobial agents
10/30/2003US20030203356 RNase L activator-antisense complexes
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202988 Attenuated mutant; induce immunology response
10/30/2003US20030202987 Hepatitis virus; oligomer protein
10/30/2003US20030202985 Methods and compositions for immunotherapy of cancer
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202975 Using monoclonal antibodies; shrinkage of solid tumors
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202967 Diabetic therapy
10/30/2003US20030202963 Method of treating cancer
10/30/2003US20030202962 Antigen encoded nucleic acids; controlling cell differentiation, cell proliferation; transcription factor controller
10/30/2003US20030202961 Methods of therapy for HIV infection
10/30/2003US20030202937 Eubacterium; membrane protein; detecting signal moderated by binding
10/30/2003DE10219117C1 Use of lithium dodecyl sulfate for stabilizing RNA in solution, particularly during purification of RNA from cell lysate
10/30/2003CA2830864A1 Methods of creating modified promoters resulting in varying levels of gene expression
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483474A1 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2483338A1 Method of creating a library of bacterial clones with varying levels of gene expression
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2483006A1 Methods of creating modified promoters resulting in varying levels of gene expression
10/30/2003CA2482995A1 Low-cost production of peptides
10/30/2003CA2482993A1 Inhibition of ii expression in mammalian cells
10/30/2003CA2482919A1 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482887A1 System, substrate plate and incubation device for conducting bioassays
10/30/2003CA2482884A1 Substrate plate, method and apparatus for manufacturing such a substrate plate, and system for conducting biossays comprising such a substrate plate
10/30/2003CA2482863A1 Universal libraries for immunoglobulins
10/30/2003CA2482769A1 "doping" in walk-through mutagenesis
10/30/2003CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003CA2482719A1 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003CA2482611A1 Functionalized nanoparticles and methods of use
10/30/2003CA2482607A1 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
10/30/2003CA2482597A1 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase
10/30/2003CA2482485A1 Matrix analysis of gene expression in cells (magec)
10/30/2003CA2482481A1 Method to enhance homologous recombination
10/30/2003CA2482460A1 Regulated ethylene sensitivity to control flower longevity in a plant
10/30/2003CA2482368A1 Cytokine receptor
10/30/2003CA2481986A1 Surface transfection and expression procedure
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003CA2481507A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2481414A1 Promoter and plasmid system for genetic engineering
10/30/2003CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003CA2481171A1 Hepatitis c virus assay systems
10/30/2003CA2481108A1 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
10/30/2003CA2481085A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2475418A1 Mutation of dna polymerases from archaeobacteria
10/30/2003CA2472040A1 Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof
10/30/2003CA2427190A1 Production of recombinant epidermal growth factor in plants
10/29/2003EP1357191A1 Transgenic plants with enhanced stress tolerance
10/29/2003EP1357190A1 Methods and markers for simple transformation and selection of recombinant ciliates
10/29/2003EP1357189A2 Elicitor of the hypersensitive response in plants
10/29/2003EP1357188A1 Improvement of plant flower type targeting mads box gene
10/29/2003EP1357187A1 Novel physiologically active peptide and use thereof
10/29/2003EP1357186A1 Novel proteins and dnas thereof
10/29/2003EP1357185A1 4-[(3-methyl-2(3H)-benzothiazolyliden)methylene]-quinoline and -pyridine derivatives as reporter groups in probes for analysis of nucleic acids
10/29/2003EP1357184A2 Novel cis-element decoys useful as anti-tumor therapeutics
10/29/2003EP1357183A1 Rice sucrose transporter gene promoter
10/29/2003EP1357129A2 Novel physiologically active peptide and use thereof
10/29/2003EP1357127A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes
10/29/2003EP1357126A1 Method of assaying lysophospholipase d activity
10/29/2003EP1356860A2 Quality control method of DNA microarray
10/29/2003EP1356824A2 88KDA tumorigenic growth factor and antagonists
10/29/2003EP1356821A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response INDUCED BY ADP-RIBOSYLATING EXOTOXIN
10/29/2003EP1356820A1 DNA vaccine combined with an inducer of tumor cell apoptosis
10/29/2003EP1356302A2 Method and device for collecting and stabilizing a biological sample
10/29/2003EP1356300A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides
10/29/2003EP1356298A2 Diagnosis and treatment of disease
10/29/2003EP1356293A2 Compositions and methods involving staphylococcus aureus protein staau-r9
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356285A2 Differentially expressed epitopes and uses thereof
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356281A1 Rapid and quantitative proteome analysis and related methods
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356277A2 Method for altering cell fate
10/29/2003EP1356276A2 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
1 ... 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 ... 4023